Repertoire Partners’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-474,180
Closed -$28.2M 27
2023
Q1
$28.2M Buy
474,180
+374,180
+374% +$20.8M 8.12% 3
2022
Q4
$4.88M Buy
+100,000
New +$4.62M 0.49% 16

Other funds holding THC

Repertoire Partners's THC Position: Q2 2023 in Review

Repertoire Partners sold out of Tenet Healthcare (THC) in Q2 2023, closing a stake of 474,180 shares — an estimated $28.2M sold.

Repertoire Partners first reported a position in THC in Q4 2022 and held it in 2 quarters. The position peaked at $28.2M in Q1 2023. 417 funds tracked by Wall St. Rank hold THC as of Q2 2023.

  • Repertoire Partners reported no remaining Tenet Healthcare position as of Q2 2023 after selling out during the quarter.
  • Repertoire Partners sold 474,180 Tenet Healthcare shares in Q2 2023, an estimated $28.2M.
  • Repertoire Partners first reported a position in Tenet Healthcare in Q4 2022 and held it in 2 quarters.
  • Repertoire Partners's Tenet Healthcare position peaked at $28.2M in Q1 2023.
  • 417 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2023.

Based on Repertoire Partners's 13F filing for Q2 2023, filed 14 Aug 2023.